Michael Savona

57PUBLICATIONS
368CO-AUTHORS
Molecular targetsHaematological tumoursBiologically active moleculesPredictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Jul 29, 2026
Specific F1 ATP synthase inhibition delivers transient mitochondrial stress for selective targeting of acute myeloid leukemia.

|Apr 10, 2026
Mutation-specific impairment of TET2 and DNMT3A enzymatic activity predicts clonal hematopoiesis disease risk.

Yash Pershad, Kun Zhao, Joseph C Van Amburg

|Mar 31, 2026
Spirocyclic β-lactone secondary metabolites modulate spliceosome function.

Kathryn E Penton, Sydney A Bates, Hannah L Thirman

|Mar 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.

Luca Lanino, Anthony M Hunter, Nico Gagelmann

|Mar 09, 2026
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia.

Somedeb Ball, Farrukh T Awan, Ben K Tomlinson

|Feb 24, 2026
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy.

Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos

Pageof 10

Frequent Collaborators

11 joint publications

Alexander James Silver

9 joint publications

Rafael Bejar

8 joint publications

Benjamin L Ebert

8 joint publications

Alexander G Bick